accuray.com (ARAY) - Total Stockholders' Equity

ARAY (accuray.com) - company brandmark

The financial price visualization for Accuray Incorporated (ARAY) demonstrates the dynamics of an asset whose margins are expanding due to service maintenance amid slow equipment production, which currently stands at 0.04. The business relies on long-term clinic budgets and remains crisis-resistant. Software integration into irradiation systems creates strong lock-in for medical centers to the brand's technologies, ensuring high therapy precision.

ARAY Accuray Inc. Book Capitalization (07/04/2022 - 10/27/2026)
Mass-produced product of Accuray Inc.

Book value capitalization reflects the value of the issuer's net assets as recorded in the financial statements. Analyzing the firm's book capitalization allows for the identification of the gap between market quotes and actual capital. Growth in this metric indicates a strengthening financial foundation, excluding speculative influence. For Accuray Incorporated (ARAY), this confirms the resilience of the asset base during the implementation of high-cost robotic systems. Stable revenue from services and software minimizes the risks of a cyclical decline in capital value.

Competitors of Accuray Incorporated

BeiGene Oncology (ONC) - Book Capitalization|Company Net Assets HALO|revmed.com (RVMD) - Total Stockholders' Equity|Book Capitalization AAPG|Company Net Assets CG Oncology Inc|Book Capitalization URGN|Book Capitalization BCAX (Bicara Corp)|PSNL - Company Book Value|Accounting Capitalization erasca.com ERAS|DCTH: Book Capitalization|YMAB - Company Net Assets|Book Capitalization AURA|CADL (Candel Therapeutics, Inc.) - Total Stockholders' Equity|SLS - Company Book Value|Accounting Value of Company actuatetherapeutics.com (ACTU)|Citius Oncology (CTOR) - Company Net Assets|Accounting Value of Company tuhurabio.com (HURA)|Protara - Book Capitalization|FATE - Company Net Assets|Aadi Bio - Company Net Assets|TCRX: Book Capitalization|Company Book Value championsoncology.com CSBR|XBiotech (XBIT) - Accounting Value of Company|Book Capitalization CVM (CEL-SCI Corp.)|Total Stockholders' Equity OS Therapies, Inc.|Book Capitalization RADX|Book Capitalization artivabio.com (ARTV)|Adlai Nortye - Book Capitalization|Company Net Assets Veru Inc VERU|TPST: Book Capitalization|Xilio Therapeutics, Inc. (XLO) - Company Net Assets|RENB: Company Net Assets|MURA (Mural Oncology) - Book Capitalization|KAPA - Company Book Value|Accounting Value of Company OnKure|Book Capitalization GDTC|Book Capitalization curis.com CRIS|APLM: Company Net Assets|THAR - Total Stockholders' Equity|Company Net Assets Advanced Biomed Corp (ADVB)|GNPX - Accounting Value of Company|calidibio.com - Book Capitalization|SBFM (Sunshine Biopharma Inc.) - Book Valuation of Business|Company Book Value Xenetic Biosciences Inc. (XBIO)|Accounting Capitalization salariuspharma.com|Book Capitalization PPBT (Purple Biotech Ltd.)|Company Net Assets AONC (aoncology.com)|BGNE: Company Book Value|Checkpoint Therapeutics Inc - Total Stockholders' Equity|Company Book Value Elevation Oncology, Inc. (ELEV)|ICAD: Accounting Value of Company|Company Book Value ikenaoncology.com (IKNA)|NTBL (Notable Labs Ltd) - Net Asset Value|Company Book Value VIRX (Viracta Therapeutics Inc.)|Total Stockholders' Equity MOR|NAYA Biosciences (NAYA) - Company Book Value|Accounting Value of Company ascentage.com (AAPGV)